Genomics, Inc. (NASDAQ:TXG – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the ...
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...
(see more details here) 10x Genomics, Inc. (NASDAQ:TXG) is a U.S.-based life science technology company. Its solutions include biological system analysis software, consumables, and devices.
X Genomics Inc (TXG) stock saw a decline, ending the day at $14.84 which represents a decrease of $-0.01 or -0.07% from the prior close of $14.85. The stock opened at $14.99 and touched a low of ...
Stay informed and make strategic decisions with our Ratings Table. 10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables ...
Nisa Investment Advisors LLC acquired a new position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) in the 4th quarter, HoldingsChannel reports. The firm acquired 16,500 shares of the ...
10x Genomics (TXG) Company Description: 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated ...
In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on 10x Genomics (TXG – Research Report).
X Genomics Inc (TXG) stock saw a decline, ending the day at $15.08 which represents a decrease of $-0.01 or -0.07% from the prior close of $15.09. The stock opened at $15.46 and touched a low of $14.9 ...
10x Genomics excels in single-cell and spatial ... explore molecular data within its spatial context. The firm's GEM-X technology aims to reduce the cost of this work for researchers, and make ...
10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, ...